TONIX PHARMACEUTICALS HOLDING CORP. Share-based Payment Arrangement, Expensed and Capitalized, Amount
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $100.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2015-11-06
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2015-09-30 was $100.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2015-06-30 was $65.52K.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2014-09-30 was $0.00.
- TONIX PHARMACEUTICALS HOLDING CORP. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2014-06-30 was $0.00.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 9 month |
|---|---|---|---|
| 2015-09-30 | $100.00K 10-Q · filed 2015-11-06 | $165.52K derived: sum of 2 quarters · filed 2015-11-06 | $200.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $65.52K 10-Q · filed 2015-08-07 | $87.36K 10-Q · filed 2015-08-07 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-07 | $0.00 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |